Today: 27 June 2026
COHR Stock Faces a May Test After CFO’s $702,000 Sale
26 April 2026
2 mins read

COHR Stock Faces a May Test After CFO’s $702,000 Sale

SAXONBURG, Pennsylvania, April 26, 2026, 12:00 EDT

Coherent Corp Chief Financial Officer Sherri Luther sold 2,000 shares for $702,000 under a Rule 10b5-1 trading plan, a pre-set schedule for insider trades, an SEC filing dated April 24 showed. The shares were sold on April 22 at $351 each, and Luther still held 70,475 shares directly after the transaction.

The timing puts the filing in front of Coherent’s next numbers. The photonics supplier — photonics means technology that uses light, including lasers and optical links — is due to report fiscal third-quarter results on May 6 after the New York Stock Exchange closes, followed by a 4:30 p.m. ET webcast.

That is why the filing will travel farther than its size. It lands before management has to explain how fast Coherent can add capacity for AI data-center customers and whether demand is still running ahead of supply.

With U.S. markets closed for the weekend, Coherent was last quoted at $336.09, off $1.61 from the previous close, with a market value of about $63.0 billion. Friday’s intraday range was $326.52 to $344.70, leaving the CFO’s sale price above the latest quote.

Coherent’s last full update set the bar. In February, it projected fiscal third-quarter revenue between $1.70 billion and $1.84 billion and adjusted earnings per share of $1.28 to $1.48; adjusted, or non-GAAP, figures strip out some costs and non-cash items and are not a substitute for standard GAAP results. CEO Jim Anderson said growth in the December quarter was driven by “strong demand” in datacenter and communications, while Luther said the company was moving to “ramp” capital investment for capacity. Coherent Inc

Nvidia gave the story a harder strategic frame in March. The chipmaker said it would invest $2 billion in Coherent and secure future access and capacity rights for advanced laser and optical networking products; Nvidia CEO Jensen Huang said the companies were working on next-generation silicon photonics, a light-based way to move data through chip and networking systems, to scale AI infrastructure.

The competitive context is narrow but important. Peer Lumentum, another optical and photonic technology supplier, received its own $2 billion Nvidia agreement, and Lumentum CEO Michael Hurlston said the company was investing in a new fabrication facility to increase capacity.

Index flows have added another layer. Reuters reported last month that S&P Dow Jones Indices said photonics product makers Lumentum and Coherent would join the S&P 500 before the March 23 open, a change that can draw buying from funds that track the benchmark.

But the setup cuts both ways. Coherent’s March 8-K showed Nvidia bought 7,788,161 Coherent shares at $256.80 each for $2 billion in cash, yet the same filing warned that the purchase agreement or collaboration could be amended or terminated and that unexpected costs or business reactions could hurt results.

The May 6 call will therefore be less about the insider sale itself and more about proof. Investors will be listening for capacity timing, customer orders and margins; a clean quarter would keep the AI optics case intact, while a miss would make the premium harder to defend.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Schaeffler Stock Drops 28% in One Month, DCF Model Indicates Overvaluation
    June 27, 2026, 10:33 AM EDT. Schaeffler (XTRA:SHA0) shares have fallen 28.7% over the last month, dropping to €7.86 despite a 75.5% return over the past year. A Discounted Cash Flow (DCF) analysis, which estimates company value based on future cash flows discounted to present day, values the stock at €5.74, suggesting it is trading about 37% above its intrinsic worth. The stock holds a middling valuation score of 3 out of 6. Investors remain watchful given the pullback, reassessing potential risks and opportunities. The DCF approach focuses on cash flows available to shareholders rather than short-term market sentiment, and points to possible overvaluation amid recent price declines.

Latest articles

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Court ruling on student loans hits private lenders’ health grad loan push

Court ruling on student loans hits private lenders’ health grad loan push

27 June 2026
Judge blocks narrow “professional degree” rule, letting more health-care grad students keep higher federal loan caps; $7.87B in 2023-24 borrowing above new limits remains in federal market, trimming but not eliminating the $4.5B-$5B annual private loan growth Sallie Mae projected from Grad PLUS loan cuts.
Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

27 June 2026
Moderna soared 12.6% Friday on heavy volume after unveiling new in vivo CAR-T pipeline plans, closing at $67.27—52% above the mean analyst target but still 14.5% below Piper Sandler’s new $77 target. The rally followed Science Day updates, even as analysts note the main new asset is preclinical and cash burn continues, with $7.5B cash at March-end and a projected $3B R&D spend for 2026.
Atomera Stock Jumps Nearly 50% After Synopsys Deal Puts GaN Chip Tech in Focus
Previous Story

Atomera Stock Jumps Nearly 50% After Synopsys Deal Puts GaN Chip Tech in Focus

Dow Jones Today: Oil Spike, Fed Week and Big Tech Earnings Put Rally on Edge
Next Story

Dow Jones Today: Oil Spike, Fed Week and Big Tech Earnings Put Rally on Edge

Go toTop